2YKL

structure of human anti-nicotine fab fragment in complex with nicotine-11-yl-methyl-(4-ethylamino-4-oxo)-butanoate

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: H-L
  • Int. Res.: 157
  • Norm. En. per Res.: -2.9027
• Hub Node: H(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
H-L	-38.6288	-35.7766	-381.316	-455.7214	157	9	11	14934	3	11	9

Interface residues

• H-L: ALA134L, ALA172H, ALA177L, ALA178L, ALA44L, ALA90L, ALA98L, ARG34H, ARG51L, ARG55L, ASN173L, ASN56H, ASP142L, ASP148H, ASP86L, ASP93L, ASP97H, CYS138L, CYS144H, CYS89L, CYS91H, GLN109H, GLN171L, GLN175H, GLN35H, GLN38L, GLN39L, GLN54L, GLU105H, GLU164L, GLU42H, GLU6H, GLY102L, GLY103H, GLY103L, GLY104L, GLY108H, GLY110H, GLY143H, GLY162L, GLY178H, GLY31H, GLY38H, GLY40H, GLY42L, GLY45H, GLY58L, GLY96H, HIS168H, ILE140L, ILE29H, ILE33H, ILE44H, ILE47H, ILE49L, LEU101H, LEU106H, LEU121L, LEU128H, LEU136L, LEU139L, LEU142H, LEU145H, LEU174H, LEU182H, LEU184L, LEU40L, LEU41H, LEU47L, LEU48L, LEU96L, LEU98H, LYS102H, LYS147H, LYS170L, LYS175L, LYS39H, LYS46L, PHE101L, PHE122L, PHE126H, PHE143L, PHE170H, PHE95H, PRO123L, PRO124L, PRO127H, PRO168L, PRO171H, PRO36H, PRO41L, PRO45L, PRO56L, PRO57H, SER100H, SER118L, SER125L, SER126L, SER141L, SER169L, SER172L, SER176H, SER177H, SER179L, SER180L, SER181H, SER183H, SER183L, SER184H, SER46H, SER52H, SER57L, SER58H, SER95L, SER97L, THR120L, THR135L, THR165L, THR166L, THR167L, THR169H, THR43L, THR53H, TRP107H, TRP32H, TRP36L, TRP43H, TRP92L, TRP94H, TRP99L, TYR149H, TYR176L, TYR180H, TYR181L, TYR35L, TYR37L, TYR48H, TYR50L, TYR54H, TYR55H, TYR87L, TYR88L, TYR90H, VAL100L, VAL104H, VAL119L, VAL125H, VAL137L, VAL146H, VAL163L, VAL167H, VAL173H, VAL185H, VAL186H, VAL59L, VAL88H, VAL92H